QHSLab, Inc.
USAQ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.92M
Close$
$-0.40
223.9% downside
Current Fair Value
223.9% downsideOvervalued by 223.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $6.92 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0.04 |
| Beta | 0.65 |
| Outstanding Shares | 15,032,788 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 9.7 |
|---|---|
| PEG | -5.65 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.01
Consensus analyst estimateRevenue Estimate
$300,000
Consensus analyst estimateNext Earnings Call
Expected Date
November 17, 2026
EPS Estimate
$-0.01
Consensus analyst estimateRevenue Estimate
$300,000
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About QHSLab, Inc.
12 employees
CEO: Troy James Grogan
QHSLab, Inc. is a company operating in the medical technology and Software-as-a-Service (SaaS) sectors. Its core focus is on advancing value-based healthcare, medical informatics, and personalized medicine driven by algorithms. The firm ...